logo

For the Inventor, By the Inventor

Camarillo, CA, United States of America

David Joseph St Jean, Jr

This inventor holds 13 USPTO granted patents. Top assignees: Amgen Inc., Cytokinetics, Inc., Biovitrum Ab. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Joseph St Jean, Jr. Retrieved from https://idiyas.com/inventor/david-joseph-st-jean-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 69.2

Average Co-Inventor Count = 14.3

ph-index = 4

Forward Citations = 47(Granted Patents)


Location History:

  • Camarillo, CA (US) (2007 - 2016)
  • Natick, MA (US) (2020 - 2023)

Company Filing History:

goldMedal13 out of 2,074 
 
Amgen Inc.
 patents
silverMedal5 out of 261 
 
Cytokinetics, Inc.
 patents
bronzeMedal3 out of 55 
 
Biovitrum Ab
 patents
where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...
13 patents (USPTO):Explore Patents
1. 11780826 - Bisamide sarcomere activating compounds and uses thereof (2023-10-10),
2. 11299479 - Bisamide sarcomere activating compounds and uses thereof (2022-04-12),
3. 11254658 - Bisamide sarcomere activating compounds and uses thereof (2022-02-22),
4. 10899746 - Bisamide sarcomere activating compounds and uses thereof (2021-01-26),
5. 10723720 - Bisamide sarcomere activating compounds and uses therof (2020-07-28),
6. 9296698 - Amino heteroaryl compounds as beta-secretase modulators and methods of use (2016-03-29),
7. 9096527 - TRPM8 antagonists and their use in treatments (2015-08-04),
8. 8686011 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2014-04-01),
9. 8541592 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (2013-09-24),
10. 8431563 - Compounds that interact with glucokinase regulatory protein for the treatment of diabetes (2013-04-30),
11. 8334317 - Calcium receptor modulating agents (2012-12-18),
12. 7807700 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2010-10-05),
13. 7253196 - Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 (2007-08-07),

Title: The Innovative Mind of David Joseph St Jean, Jr

Introduction: David Joseph St Jean, Jr is a visionary inventor based in Camarillo, California. His passion for creating groundbreaking solutions has led to numerous patents and innovations in various industries.

Latest Patents: David Joseph St Jean, Jr holds several recent patents in the fields of renewable energy technology, medical devices, and sustainable agriculture practices. His inventions have been recognized for their ingenuity and practical applications.

Career Highlights: With a background in engineering and a keen eye for identifying gaps in the market, David Joseph St Jean, Jr has successfully brought several products from concept to commercialization. His dedication to pushing the boundaries of what is possible has earned him a reputation as a forward-thinker in the inventor community.

Collaborations: Throughout his career, David Joseph St Jean, Jr has collaborated with leading researchers, engineers, and industry experts to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: David Joseph St Jean, Jr's relentless pursuit of innovation and his commitment to making a positive impact on the world through his inventions make him a standout figure in the field of inventors. His contributions continue to inspire the next generation of innovators to think outside the box and create solutions that shape the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…